Covered recipient · General Payments record
JALEE M JOHN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2022–2024
$545.68
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $273.78 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $68.58 | 4 |
| ABBVIE INC. | $40.79 | 2 |
| SHIELD THERAPEUTICS INC | $40.37 | 2 |
| Biogen, Inc. | $32.93 | 2 |
| Solventum Corporation | $28.24 | 2 |
| Lilly USA, LLC | $19.27 | 1 |
| PFIZER INC. | $16.26 | 1 |
| Exeltis, USA Inc. | $15.03 | 1 |
| Organon LLC | $12.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.21 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999141 | CMS |
| ABBVIE INC. | $16.58 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103999143 | CMS |
| Astellas Pharma US Inc | $17.02 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139266038 | CMS |
| Astellas Pharma US Inc | $19.48 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139321566 | CMS |
| Astellas Pharma US Inc | $18.84 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139354397 | CMS |
| Astellas Pharma US Inc | $13.24 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139444268 | CMS |
| Biogen, Inc. | $15.49 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104821276 | CMS |
| Biogen, Inc. | $17.44 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104843326 | CMS |
| Exeltis, USA Inc. | $15.03 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149996238 | CMS |
| Lilly USA, LLC | $19.27 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135016348 | CMS |
| Organon Llc | $12.31 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136194416 | CMS |
| PFIZER INC. | $16.26 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132042494 | CMS |
| SHIELD THERAPEUTICS INC | $15.91 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150122029 | CMS |
| SHIELD THERAPEUTICS INC | $24.46 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150148519 | CMS |
| Solventum Corporation | $15.16 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144070310 | CMS |
| Solventum Corporation | $13.08 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144070312 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.